Document Page: First | Prev | Next | All | Image | This Release | Search
File: 970101_sep96_decls27_0021.txt
Subject: USAMRICD TECH MEMO 90 1 CLINICAL NOTES ON CHEM CASUALTY CARE
Unit: OTSG
Parent Organization: HSC
Box ID: BX003205
Folder Title: CLINICAL NOTES ON CHEMICAL CASUALTY CARE
Document Number: 1
Folder Seq #: 31
AUG 16 '90 11:46 P.21
u CD Technical Memorandum 90-1
coughing, dyapnea, secretions; necrotic mucosa in
airways with paeudomembrane formation
4. Systemic
a. Available data suggest an increase in
capillary permeability with fluid loss leading to
hemooonoontration and shook. There may be
hepatic and renal congestion/necroBis along with
gastrointestinal effects (vomiting, diarrhea)
M. Treatment
1. Immediate decontamination is a must if severe and
p @ anent damage is to be prevented, especially in
the eye
2. Dinercaprol (British Anti-Lewisite; BAL) will bind
Lewisite and decrease its effects. It should be
applied to the eye (BAL ophthalmic ointment) and
skin (BAL ointment) immediately after thorough
decontamination. It can also be given
systemically (BAL-in-oil) to reduce systemic
effects. BAL is not innocuous and one should be
aware of its side effects before using.
3. Silver sulfadiazine might be used for topical care
(see mustard therapy) after lesions develop.
Should not be applied over BAL as it will
neutralize it. BAL should be applied early, as
soon as possible; sulfadiazine is for later care.
4. Supportive care similar to that for mustard, with
particular attention to hypovolenia, shock
dimercaptosuccinic
acid), DMPS (2,3-dimarcapto-i-propanesulfonic
acid), and DMPA (N-(2,3-dimercaptopropyl)-
ghthalamidic acid) are in experimental stage and
may offer advantages over BAL.
N. Long term effects
1. Fe data
51. PROSGENE OXIME
A. Acronym is CX; very little biological data; do not
confuse with phosgene (CG)
B. Is an urticant or corrosive; causes immediate pain and
later necrosis of skin by vapor or as liquid
C. Has very disagreeable odor
D. Data lacking on vapor density, liquid density,
volatility
E. Toxicity (dogs; very little data)
Lethal by inhalation 1500--2000 mg/cu n
Lethal, percutaneous 25 mglkg
F. Mechanism of action--not reported
C. May be used in 'mixture; irritancy will cause mask
removal and greater exposure to second agent
20
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 22 f:/Week-36/BX003205/CLINICAL NOTES ON CHEMICAL CASUALTY CARE/usamricd tech memo 90 1 clinical notes on chem c:12249609312728
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003205
Unit = OTSG
Parent Organization = HSC
Folder Title = CLINICAL NOTES ON CHEMICAL CASUALTY CARE
Folder Seq # = 31
Subject = USAMRICD TECH MEMO 90 1 CLINICAL NOTES ON CHEM C
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 24-DEC-1996